Positive association of the vascular endothelial growth factor-A +405 GG genotype and poor survival in stage I-II gastric cancer in the Northern Chinese population

Molecular Biology Reports

Volumn 40, Issue 3, 2013, Pages 2741-2748

  Li, Ailin ^a   Gao, Peng ^a   Wang, Zhenning ^a   Song, Yongxi ^a   Xu, Yingying ^a   Miao, Yuan ^a   Zhu, Jinliang ^a   Xu, Huimian ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Gastric cancer; Single nucleotide polymorphism (SNP); Vascular endothelial growth factor A (VEGF A)

Indexed keywords

BIOLOGICAL MARKER; CYTOSINE; GUANINE; THYMINE; VASCULOTROPIN A;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CHINESE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENETIC CORRELATION; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HUMAN; HUMAN TISSUE; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; POPULATION RESEARCH; PROTEIN FUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; FEMALE; GENE ORDER; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; STOMACH NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84878402023     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-2365-6     Document Type: Article

References (34)

1. Zhang YJ, Fang JY (2008) Molecular staging of gastric cancer. J Gastroenterol Hepatol 23(6):856-860
2. Vitale A, Navaglia F, Ramirez Morales R, Frigo AC, Basso D, D'Amico F, Zanus G, Bonsignore P, Farinati F, Burra P, Senzolo M, Grigoletto F, Plebani M, Cillo U (2011) Molecular refinement of clinical staging in hepatocellular carcinoma patients evaluated for potentially curative therapies. PLoS One 6(9):e23093
3. Peng L, Zhan P, Zhou Y, Fang W, Zhao P, Zheng Y, Xu N (2012) Prognostic significance of vascular endothelial growth factor immunohistochemical expression in gastric cancer: a meta-analysis. Mol Biol Rep 39(10):9473-9484
4. Lu Y, Shi Y, Xue C, Yin J, Huang Z (2012) Pooled-analysis of the associations between three polymorphisms in the VEGF gene and age-related macular degeneration. Mol Biol Rep 39(6):6547-6553
5. Shih T, Lindley C (2006) Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies. Clin Ther 28(11):1779-1802
6. Iordache S, Saftoiu A, Georgescu CV, Ramboiu S, Gheonea DI, Filip M, Schenker M, Ciurea T (2010) Vascular endothelial growth factor expression and microvessel density - two useful tools for the assessment of prognosis and survival in gastric cancer patients. J Gastrointestin Liver Dis 19(2):135-139
7. Xu B, Feng NH, Tong N, Wang ZD, Zhang W, Wu HF, Hua LX (2010) VEGF -460C>T polymorphism and cancer risk: a meta-analysis. Med Oncol 27(4):1031-1036
8. Hamedian AA, Esteghamati A, Noshad S, Mozafari M, Moin-Tavakkoli H, Nakhjavani M, Mahmoudi T, Nikzamir M, Safary R, Nikzamir A (2012) Vascular endothelial growth factor (VEGF) +405 C/G polymorphism is associated with essential hypertension in a population from Tehran of Iran. Mol Biol Rep 39(5):6213-6218
9. Jain L, Vargo CA, Danesi R, Sissung TM, Price DK, Venzon D, Venitz J, Figg WD (2009) The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors. Mol Cancer Ther 8(9):2496-2508
10. Zablotna M, Sobjanek M, Nedoszytko B, Lange M, Kozicka D, Glen J, Roszkiewicz J (2011) Association of psoriasis with the VEGF gene polymorphism in the northern Polish population. J Eur Acad Dermatol Venereol. doi: 10.1111/j.1468-3083.2011.04393.x
11. Cacev T, Loncar B, Seiwerth S, Spaventi S, Kapitanovic S (2008) Vascular endothelial growth factor polymorphisms -1154 G/A and -460 C/T are not associated with VEGF mRNA expression and susceptibility to sporadic colon cancer. DNA Cell Biol 27(10):569-574
12. Chen MH, Tzeng CH, Chen PM, Lin JK, Lin TC, Chen WS, Jiang JK, Wang HS, Wang WS (2011) VEGF -460T → C polymorphism and its association with VEGF expression and outcome to FOLFOX-4 treatment in patients with colorectal carcinoma. Pharmacogenomics J 11(3):227-236
13. Steffensen KD, Waldstrom M, Brandslund I, Jakobsen A (2011) The relationship of VEGF polymorphisms with serum VEGF levels and progression-free survival in patients with epithelial ovarian cancer. Gynecol Oncol 117(1):109-116
14. Balasubramanian SP, Cox A, Cross SS, Higham SE, Brown NJ, Reed MW (2007) Influence of VEGF-A gene variation and protein levels in breast cancer susceptibility and severity. Int J Cancer 121(5):1009-1016
15. Chen Y, Dawes PT, Mattey DL (2012) Polymorphism in the vascular endothelial growth factor A (VEGFA) gene is associated with serum VEGF-A level and disease activity in rheumatoid arthritis: differential effect of cigarette smoking. Cytokine 58(3):390-397
16. Watson CJ, Webb NJ, Bottomley MJ, Brenchley PE (2000) Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 12(8):1232-1235
17. Kim YH, Kim MA, Park IA, Park WY, Kim JW, Kim SC, Park NH, Song YS, Kang SB (2010) VEGF polymorphisms in early cervical cancer susceptibility, angiogenesis, and survival. Gynecol Oncol 119(2):232-236
18. Liu L, Liu L, Zeng F, Wang K, Huang J, Xin L, Zhu PQ (2011) Meta-analysis of the association between VEGF-634 G>C and risk of malignancy based on 23 case-control studies. J Cancer Res Clin Oncol 137(6):1027-1036
19. Yamamori M, Sakaeda T, Nakamura T, Okamura N, Tamura T, Aoyama N, Kamigaki T, Ohno M, Shirakawa T, Gotoh A, Kuroda Y, Matsuo M, Kasuga M, Okumura K (2004) Association of VEGF genotype with mRNA level in colorectal adenocarcinomas. Biochem Biophys Res Commun 325(1):144-150
20. Zhai R, Gong MN, Zhou W, Thompson TB, Kraft P, Su L, Christiani DC (2007) Genotypes and haplotypes of the VEGF gene are associated with higher mortality and lower VEGF plasma levels in patients with ARDS. Thorax 62(8):718-722
21. Jaremko M, Justenhoven C, Abraham BK, Schroth W, Fritz P, Brod S, Vollmert C, Illig T, Brauch H (2005) MALDI-TOF MS and TaqMan assisted SNP genotyping of DNA isolated from formalin-fixed and paraffin-embedded tissues (FFPET). Hum Mutat 25(3):232-238
22. Horn H, Pott C, Kalla J, Dreyling M, Rosenwald A, Ott G, Schwab M, Schaeffeler E (2010) A multiplex MALDI-TOF MS approach facilitates genotyping of DNA from formalin-fixed paraffin-embedded tumour specimens. Pharmacogenet Genomics 20(10):598-604
23. Li AL, Song YX, Wang ZN, Gao P, Miao Y, Zhu JL, Yue ZY, Xu HM (2012) Polymorphisms and a haplotype in heparanase gene associations with the progression and prognosis of gastric cancer in a northern Chinese population. PLoS One 7(1):e30277
24. Tregouet DA, Tiret L (2004) Cox proportional hazards survival regression in haplotype-based association analysis using the Stochastic-EM algorithm. Eur J Hum Genet 12(11):971-974
25. Ke Q, Liang J, Wang LN, Hu ZB, Jin GF, Zhou Y, Wang JM, Tan YF, Hua ZL, Xu YC, Shen J, Shen HB (2008) Potentially functional polymorphisms of the vascular endothelial growth factor gene and risk of gastric cancer. Mol Carcinog 47(8):647-651
26. Chae YS, Kim JG, Sohn SK, Cho YY, Moon JH, Bae HI, Park JY, Lee MH, Lee HC, Chung HY, Yu W (2006) Investigation of vascular endothelial growth factor gene polymorphisms and its association with clinicopathologic characteristics in gastric cancer. Oncology 71(3-4):266-272
27. Cao C, Fang JJ, Ying T, Sun SF, Lv D, Chen ZB, Ma HY, Yu YM, Ding QL, Shu LH, Deng ZC (2010) Vascular endothelial growth factor +936C/T and +405G/C polymorphisms and cancer risk: a meta-analysis. Arch Med Res 41(7):548-557
28. Yue Z, Song Y, Wang Z, Luo Y, Jiang L, Xing L, Xu H, Zhang X (2010) Association of heparanase gene (HPSE-1) single nucleotide polymorphisms with gastric cancer. J Surg Oncol 102(1):68-72
29. Zhou Y, Li N, Zhuang W, Wu X (2011) Vascular endothelial growth factor (VEGF) gene polymorphisms and gastric cancer risk in a Chinese Han population. Mol Carcinog 50(3):184-188
30. Tzanakis N, Gazouli M, Rallis G, Giannopoulos G, Papaconstantinou I, Theodoropoulos G, Pikoulis E, Tsigris C, Karakitsos P, Peros G, Nikiteas N (2006) Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival. J Surg Oncol 94(7):624-630
31. Al-Moundhri MS, Al-Nabhani M, Burney IA, Al-Farsi AA, Al-Bahrani B (2009) Gastric cancer risk predisposition and prognostic significance of vascular endothelial growth factor (VEGF) gene polymorphisms - a case-control study in an Omani population. Mol Carcinog 48(12):1170-1176
32. Guan X, Zhao H, Niu J, Tan D, Ajani JA, Wei Q (2009) Polymorphisms of TGFB1 and VEGF genes and survival of patients with gastric cancer. J Exp Clin Cancer Res 28:94
33. Heist RS, Zhai R, Liu G, Zhou W, Lin X, Su L, Asomaning K, Lynch TJ, Wain JC, Christiani DC (2008) VEGF polymorphisms and survival in early-stage non-small-cell lung cancer. J Clin Oncol 26(6):856-862
34. Stevens A, Soden J, Brenchley PE, Ralph S, Ray DW (2003) Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Res 63(4):812-816